• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Know what common glaucoma mistakes to avoid

Article

Misdiagnosing neuropathy and over-reliance on OCT imaging results are two examples

Glaucoma in eye

Because glaucoma is one of the most prevalent eye diseases in the world, ODs are familiar with best practices for glaucoma management.

But do they really understand glaucoma care as well as they think?

As it turns out, maybe not.

That is according to Joseph Sowka, OD, FAAO, at Nova Southeastern University College of Optometry at the American Academy of Optometry 2019 annual meeting in Orlando.

In particular, optometrists should be aware of several pervasive mistakes in glaucoma management in order to deliver better care to their patients.

Misdiagnosing non-arteritic anterior ischemic optic neuropathy
More than anything else, ODs should avoid diagnosing non-arteritic anterior ischemic optic neuropathy (NAAION) in glaucoma patients.

“It just doesn’t happen,” Dr. Sowka says.

The danger lies in the fact that there is no clinical test to conclusively diagnose this condition, making it a common diagnosis of convenience.

A key differentiator for ODs to keep in mind is that glaucoma is a disease of cupping, while NAAION is a disease of non-cupping.

Over-reliance on OCT
Optical coherence tomography (OCT) is an indispensable tool for diagnosing glaucoma, but a common pitfall inexperienced providers face is overreliance on this imaging.

“The overuse and overemphasis on imaging technology to the exclusion of the other clinical findings and assessment of risk factors is going to put yourself and the patient in some degree of peril,” Dr. Sowka says.

In particular, imaging concerns such as signal quality, blink rates, or segmentation errors can produce erroneous data.

So how much confidence should ODs have in their OCTs for diagnosing glaucoma?

Related: Keep an eye on link between glaucoma and blood pressure

According to Dr. Sowka, optometrists should trust their initial evaluations while factoring in the imaging results. In other words, they should ask themselves how certain they were the patient had glaucoma prior to looking at the OCT imaging results.

“The OCT should not completely change your opinion or your paradigm,” he says.

Thinking that glaucoma causes disc pallor
Another common pitfall optometrists face is the belief that glaucoma causes disc pallor.

As a rule, pallor, in excess of cupping, indicates something other than, or in addition to, glaucoma. Optometrists should assess the physiology of the disc to find clues about which conditions may be present.

“Nothing notches a nerve like glaucoma,” Dr. Sowka says.

Related: Know the hidden links among glaucoma, contact lenses, and the cornea

Tools such as visual fields used in conjunction with nerve fiber analyses, medical histories, and physical assessments are critical for analyzing these conditions.

“We still need to perform fields in the age of imaging because sometimes it is not glaucoma,” he says.

Mismanagement of red and green diseases
When a disease state masquerades as another condition, it is common for testing values or imaging to fall outside of expected values.

But just because a value falls outside of a standard range, that does not necessarily mean a problem exists. This phenomenon is known as red disease.

“This is a new clinical non-entity,” Dr. Sowka says.

Conversely, there may be glaucomatous processes in a patient masquerading as non-disease. This is known as green disease.

Both of these outcomes tend to increase in prevalence when optometrists place too much trust in imaging tools and machines to make diagnoses. Often, the data inputs that make these decisions may be fallacious.

“Don’t make clinical decisions based on bad data,” Dr. Sowka says.

More by Greg Hill: How to succeed with multifocal contact lenses
 

Related Videos
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Melissa Tawa, OD, FAAO
Deborah Ristvedt, DO, details CIME 2024 presentation on glaucoma management
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
© 2024 MJH Life Sciences

All rights reserved.